Excellent point and not accurately represented in both NY Times articles. They were nominated to be included in the bulk list, but were withdrawn. www.fda.gov/drugs/human-...
Substances in Compounding that May Present Significant Safety RisksCategory 2 of the Bulk Substances Nominated Under Sections 503A or 503B of the Federal Food, Drug, and Cosmetic Actwww.fda.gov